SI9520136A - Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception - Google Patents

Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception Download PDF

Info

Publication number
SI9520136A
SI9520136A SI9520136A SI9520136A SI9520136A SI 9520136 A SI9520136 A SI 9520136A SI 9520136 A SI9520136 A SI 9520136A SI 9520136 A SI9520136 A SI 9520136A SI 9520136 A SI9520136 A SI 9520136A
Authority
SI
Slovenia
Prior art keywords
hydroxy
ester
phenyl
dien
estrogen
Prior art date
Application number
SI9520136A
Other languages
English (en)
Slovenian (sl)
Inventor
Kristof Chwalisz
Klaus Stoeckemann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SI9520136A publication Critical patent/SI9520136A/sl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
SI9520136A 1994-12-23 1995-12-23 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception SI9520136A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4447402 1994-12-23
PCT/EP1995/005106 WO1996019997A1 (de) 1994-12-23 1995-12-23 Progesteronantagonistisch- und antiöstrogen wirksame verbindungen zur gemeinsamen verwendung für die weibliche kontrazeption

Publications (1)

Publication Number Publication Date
SI9520136A true SI9520136A (en) 1997-12-31

Family

ID=6537602

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9520136A SI9520136A (en) 1994-12-23 1995-12-23 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception

Country Status (24)

Country Link
US (1) US6362237B1 (cs)
EP (1) EP0799042A1 (cs)
JP (1) JPH10511378A (cs)
KR (1) KR100385663B1 (cs)
CN (1) CN1075375C (cs)
AU (1) AU710819B2 (cs)
BG (1) BG62384B1 (cs)
BR (1) BR9510550A (cs)
CA (1) CA2208321A1 (cs)
CZ (1) CZ288062B6 (cs)
EE (1) EE03421B1 (cs)
FI (1) FI972623A0 (cs)
HU (1) HUT77519A (cs)
IL (1) IL116505A0 (cs)
LT (1) LT4291B (cs)
LV (1) LV11883B (cs)
NO (1) NO314066B1 (cs)
NZ (1) NZ298769A (cs)
PL (1) PL183843B1 (cs)
RO (1) RO121086B1 (cs)
SI (1) SI9520136A (cs)
SK (1) SK284538B6 (cs)
WO (1) WO1996019997A1 (cs)
ZA (1) ZA9510926B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19652408C2 (de) * 1996-12-06 2002-04-18 Schering Ag Steroidester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
DE19745085A1 (de) * 1997-10-11 1999-04-15 Jenapharm Gmbh 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
US6326392B1 (en) 1997-11-06 2001-12-04 American Home Products Corporation Anti-estrogen plus progestin containing oral contraceptives
DE19809845A1 (de) * 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6339098B1 (en) * 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6319912B1 (en) 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6329416B1 (en) 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
JP4382735B2 (ja) 2005-10-06 2009-12-16 独立行政法人科学技術振興機構 神経因性疼痛治療剤
BRPI0819571A2 (pt) * 2007-12-20 2019-09-24 Teva Womenss Health Inc "método para contracepção de emergência, pacote farmacêutico para contracepção de emergência e composição farmacêutica"

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2824733C2 (de) 1978-06-06 1984-03-15 Heidelberger Druckmaschinen Ag, 6900 Heidelberg Umführtrommel für Schön- und Widerdruckmaschinen
ZA8231B (en) 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
IL68222A (en) * 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
ES533260A0 (es) 1983-06-15 1985-02-01 Schering Ag Procedimiento para la preparacion de 13a-alquilgonanos
DE3322285A1 (de) 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
DE3337450A1 (de) 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
AU580843B2 (en) 1985-02-07 1989-02-02 Schering Aktiengesellschaft 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them
DE3533175A1 (de) 1985-09-13 1987-03-19 Schering Ag Antigestagene zur verschiebung der endometrialen reifung
IE60780B1 (en) 1987-01-23 1994-08-10 Akzo Nv New 11-aryl steroid derivatives
DE3708942A1 (de) 1987-03-18 1988-09-29 Schering Ag 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3866410D1 (de) 1987-04-24 1992-01-09 Akzo Nv 11-arylestranderivate und 11-arylpregnanderivate.
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren
DE3733478A1 (de) * 1987-10-01 1989-04-13 Schering Ag Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore
ATE85342T1 (de) 1987-12-12 1993-02-15 Akzo Nv 11-arylsteroid-derivate.
GB8813353D0 (en) * 1988-06-06 1988-07-13 Ici Plc Therapeutic product
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DE3926365A1 (de) 1989-08-04 1991-02-07 Schering Ag Cycloalkylenazole, verfahren zu deren herstellung, pharmazeutische praeparate, die diese enthalten sowie ihre verwendung zur herstellung von arzneimitteln
CH683151A5 (de) 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
EP0637296A4 (en) 1992-04-21 1996-02-07 Ligand Pharm Inc NON-STEROIDIAN COMPOUNDS HAVING AGONIST AND ANTAGONIST ACTIVITY IN RELATION TO THE PROGESTERONE RECEPTOR, AND METHODS OF USE.
US5439913A (en) 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein

Also Published As

Publication number Publication date
BG62384B1 (bg) 1999-10-29
SK284538B6 (sk) 2005-06-02
IL116505A0 (en) 1996-03-31
LT97107A (en) 1997-10-27
MX9704742A (es) 1997-10-31
FI972623A (fi) 1997-06-18
AU4433796A (en) 1996-07-19
KR980700866A (ko) 1998-04-30
LT4291B (lt) 1998-02-25
US6362237B1 (en) 2002-03-26
AU710819B2 (en) 1999-09-30
SK78997A3 (en) 1998-01-14
LV11883A (lv) 1997-12-20
EE03421B1 (et) 2001-06-15
CN1075375C (zh) 2001-11-28
KR100385663B1 (ko) 2003-08-19
CZ288062B6 (cs) 2001-04-11
NZ298769A (en) 2000-09-29
RO121086B1 (ro) 2006-12-29
PL320786A1 (en) 1997-10-27
EP0799042A1 (de) 1997-10-08
PL183843B1 (pl) 2002-07-31
NO972877D0 (no) 1997-06-20
NO972877L (no) 1997-08-22
EE9700143A (et) 1997-12-15
WO1996019997A1 (de) 1996-07-04
BG101553A (en) 1998-09-30
NO314066B1 (no) 2003-01-27
CZ195397A3 (en) 1997-11-12
CA2208321A1 (en) 1996-07-04
CN1171051A (zh) 1998-01-21
JPH10511378A (ja) 1998-11-04
HUT77519A (hu) 1998-05-28
BR9510550A (pt) 1998-06-16
FI972623A0 (fi) 1997-06-18
LV11883B (lv) 1998-05-20
ZA9510926B (en) 1996-07-03

Similar Documents

Publication Publication Date Title
KR100385663B1 (ko) 여성피임용으로함께사용될수있는프로게스테론길항작용및항에스트로겐작용이있는화합물
US4888331A (en) Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction
EP0912186B1 (en) Progestogen-anti-progestogen regimens
US6506390B2 (en) Progestogen-anti-progestogen regimens
SK281709B6 (sk) Viacstupňový preparát na antikoncepciu na báze prírodných estrogénov
US6143754A (en) Competitive progesterone antagonist for demand-oriented female birth control
US6642219B1 (en) Progestogen-antiprogestogen regimens
FI114687B (fi) Kitti hedelmöitymisen ehkäisemiseksi
EP1605924B1 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
WO1995005828A1 (de) PROGESTERONANTAGONISTISCH- UND ANTIÖSTROGEN WIRKSAME VERBINDUNGEN FÜR DIE BEHANDLUNG DES $i(LEIOMYOMATA UTERI)
MXPA97004742A (es) Compuestos con propiedades antagonistas de progesterona y anti-estrogeno para su uso combinado en la anticoncepcion femenina

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20090518